Abstract Diabetes mellitus has emerged as a global public health crisis, with over half of patients experiencing gastrointestinal (GI) symptoms that exacerbate glucose fluctuations and impair quality of life
7.1.2 Uses established guidelines to inform practice
Side effects can temporarily worsen after Wegovy dose increases, but this does not happen for everyone
Since one approved site wont give you an advantage over the other, the best site is whichever is easiest and most comfortable for you
Clinical data generally shows tirzepatide produces greater weight loss than semaglutide, though both are effective options
The most common side effects are gastrointestinal, including nausea (12-24%), diarrhea (13-17%), vomiting (6-10%), and constipation (5-11%)